Tolgabide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tolgabide
Tolgabide.svg
Systematic (IUPAC) name
4-{[(Z)-(3-Chloro-5-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)(4-chlorophenyl)methyl]amino}butanamide
Clinical data
Legal status
  • Uncontrolled
Identifiers
CAS number 86914-11-6
ATC code None
PubChem CID 5748792
ChemSpider 4678139
UNII 0L55QF645F YesY
KEGG D06181
ChEMBL CHEMBL2104937
Chemical data
Formula C18H18Cl2N2O2 
Mol. mass 365.25 g/mol

Tolgabide (SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed.[1] It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.[1][2]

Synthesis[edit]

Tolgabide synthesis: J. P. Kaplan, Synthélabo, DE 3242442  (1983)

See also[edit]

References[edit]